Ki67 index and S-phase fraction in human breast carcinomas. Comparison and correlations with prognostic factors.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  American Journal of Clinical Pathology

• Publication date

  1990-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/AJCP/94.6.681PMID 2244589
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Correlation of pretreatment proliferative activity of breast cancer with the response to cytotoxic chemotherapy.

  1989cited by this paper
• Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer.

  1989cited by this paper
• Nuclear distribution of the Ki-67 antigen during the cell cycle: comparison with growth fraction in human breast cancer cells.

  1989cited by this paper
• TNM atlas : illustrated guide to the TNM/pTNM-classification of malignant tumours

  1989cited by this paper
• Cell kinetics as a prognostic indicator in node-negative breast cancer.

  1989cited by this paper
• The relation of flow cytometry to clinical and biologic characteristics in women with node negative primary breast cancer

  1989cited by this paper
• Growth rate, kinetics of tumor cell proliferation and long‐term outcome in human breast cancer

  1989cited by this paper
• Cytometric characterization and clinical course of breast cancer diagnosed in a population‐based screening program

  1989cited by this paper
• Ki67 immunostaining in primary breast cancer: pathological and clinical associations.

  1989cited by this paper
• Relationship between labeling indices of KI‐67 and brdurd in human malignant tumors

  1988cited by this paper
• Measurement of cell kinetics in human tumours in vivo using bromodeoxyuridine incorporation and flow cytometry.

  1988cited by this paper
• Cell kinetics in human malignancies studied with in vivo administration of bromodeoxyuridine and flow cytometry.

  1988cited by this paper
• Comparison of monoclonal antibody Ki-67 reactivity with grade and DNA flow cytometry of breast carcinomas.

  1988cited by this paper
• The proliferative potential of human ependymomas measured by in situ bromodeoxyuridine labeling

  1988cited by this paper
• Improving the prognostic value of DNA flow cytometry in breast cancer by combining DNA index and S‐phase fraction: A proposed classification of DNA histograms in breast cancer

  1988cited by this paper
• Proliferative index of breast carcinoma by thymidine labeling: Prognostic power independent of stage, estrogen and progesterone receptors

  1988cited by this paper
• Thymidine labeling index, flow cytometric S-phase measurement, and DNA index in human tumors. Comparisons and correlations.

  1988cited by this paper
• Relevance of DNA ploidy as a measure of genetic deviation: a comparison of flow cytometry and cytogenetics in 25 cases of human breast cancer.

  1988cited by this paper
• DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens

  1988cited by this paper
• Association of DNA index and S-phase fraction with prognosis of nodes positive early breast cancer.

  1987cited by this paper
• Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene.

  1987cited by this paper
• The correlation of growth fractions with histologic grading and lymph node status in human mammary carcinoma

  1987cited by this paper
• Assessment of tumor cell kinetics by immunohistochemistry in carcinoma of breast

  1987cited by this paper
• Aneuploid DNA content and high S-phase fraction of tumour cells are related to poor prognosis in patients with primary breast cancer.

  1987cited by this paper
• Estrogen and progestin receptor assay in fine needle aspirates of breast cancer: methodological aspects.

  1987cited by this paper
• A proposed classification of breast cancer based on kinetic information derived from a comparison of risk factors in 168 primary operable breast cancers

  1986cited by this paper
• Growth fractions in breast cancers determined in situ with monoclonal antibody Ki-67.

  1986cited by this paper
• Variations in the [3H]thymidine labeling of S-phase cells in solid mouse tumors.

  1985cited by this paper
• The long‐term prognostic significance of the thymidine labelling index in breast cancer

  1984cited by this paper
• Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67.

  1984cited by this paper
• Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation

  1983cited by this paper
• Prediction of early course of breast carcinoma by thymidine labeling

  1983cited by this paper
• A comparison of mathematical methods for the analysis of DNA histograms obtained by flow cytometry

  1982cited by this paper
• Kinetic parameters and the course of the disease in breast cancer

  1981cited by this paper
• Advanced stage and early relapse of breast carcinomas associated with high thymidine labeling indices.

  1979cited by this paper
• Analysis of PCP-data to determine the fraction of cells in the various phases of cell cycle

  1975cited by this paper
• The Influence of Delay on the Natural History and Prognosis of Breast Cancer

  1965cited by this paper
• Histological Grading and Prognosis in Breast Cancer

  1957cited by this paper

• Time-Dependent Prognostic Value of Ki-67 in Early Breast Cancer: Validation of Visual and Hot-Spot Scoring Methods

  2025cites this paper
• Clinical and Analytical Validation of Two Methods for Ki-67 Scoring in Formalin Fixed and Paraffin Embedded Tissue Sections of Early Breast Cancer

  2024cites this paper
• Breast cancer research: in vitro models, markers, and in silico analysis - a narrative review

  2023cites this paper
• Ectopic expression of lncRNA MVIH as a potential diagnostic biomarker in cervical cancer

  2022cites this paper
• The Role of Transforming Growth Factor Beta and Smad Receptors in Determining Prognosis in High-Grade Primary Brain Tumors: Glioblastoma Multiforme

  2021cites this paper
• circ-ANKS1B facilitates osteosarcoma cell proliferation and invasiveness via upregulating Ki-67 expression by sponging miR-149-5p

  2020cites this paper
• Positive PCNA and Ki-67 Expression in the Testis Correlates with Spermatogenesis Dysfunction in Fluoride-Treated Rats

  2018cites this paper
• Gene protein detection platform--a comparison of a new human epidermal growth factor receptor 2 assay with conventional immunohistochemistry and fluorescence in situ hybridization platforms.

  2015cites this paper
• Role of cyclins D1 and D3 in vestibular schwannoma

  2015cites this paper
• High Expression of Three-Gene Signature Improves Prediction of Relapse-Free Survival in Estrogen Receptor-Positive and Node-Positive Breast Tumors

  2015cites this paper
• Angiogenesis in canine mammary tumours: a morphometric and prognostic study.

  2014cites this paper
• Low concordance of biomarkers in histopathological and cytological material from breast cancer

  2014cites this paper
• Lymphangiogenesis in canine mammary tumours: a morphometric and prognostic study.

  2014cites this paper
• Tumor microenvironment of metastasis and risk of distant metastasis of breast cancer.

  2014cites this paper
• Molecular Markers for Breast Cancer: Prediction on Tumor Behavior

  2014cites this paper
• Angiogenesis and lymphangiogenesis in canine mammary tumours

  2013cites this paper
• Biomarker discordance pre and post neoadjuvant chemotherapy in breast cancer

  2012cites this paper
• Iron topochemistry and surface reactivity of amphibole asbestos: relations with in vitro toxicity

  2011cites this paper
• Ki-67 biomarker in breast cancer of Indian women

  2011cites this paper
• Estudo imunohistoquimico do infiltrado de linfócitos T e da proliferação tumoral nos tumores de mama da cadela: implicações clínicas

  2009cites this paper
• BLOOM-RICHARDSON GRADING: A MARKER OF CHEMOSENSITIVITY IN INVASIVE BREAST CARCINOMAS

  2008cites this paper
• Clinocopathologic and immunohistochemical findings of multiple genital leiomyomas and mammary adenocarcinomas in a bitch.

  2008cites this paper
• S-phase Fraction as an Independent Prognostic Factor in Invasive Breast Carcinoma -A Study of Long-term Follow-up

  2007cites this paper
• Proliferation measurement in breast cancer by two different methods.

  2006cites this paper
• Prognostic significance of glycoprotein pMQ1 in breast cancer

  2006cites this paper
• Evaluation of Ki-67 proliferation and apoptotic index before, during and after neoadjuvant chemotherapy for primary breast cancer

  2006cites this paper
• Correlation of growth fraction by Ki-67 and proliferating cell nuclear antigen (PCNA) immunohistochemistry with histopathological parameters and prognosis in primary breast carcinomas

  2005cites this paper
• The S-phase fraction of the aneuploid cell subpopulation is the biologically relevant one in aneuploid breast cancers

  2005cites this paper
• Comparison of PCNA/cyclin immunohistochemistry with flow cytometric S-phase fraction in breast cancer

  2005cites this paper
• Tumor proliferative activity and response to first-line chemotherapy in advanced breast carcinoma

  2005cites this paper
• Long term prognostic value of growth fraction determination by Ki-67 immunostaining in primary operable breast cancer

  2005cites this paper
• S‐phase fraction as an independent prognostic factor of long‐term overall survival in patients with early‐stage or locally advanced invasive breast carcinoma

  2005cites this paper
• ADJUVANT THERAPY IN NODE NEGATIVE BREAST CANCER

  2004cites this paper
• Fine-needle aspiration technique for the concurrent immunocytochemical evaluation of multiple biologic parameters in primary breast carcinoma

  2004cites this paper
• Leader Biological indices in the assessment of breast cancer

  2003cites this paper
• Functional relationship and gene ontology classification of breast cancer biomarkers.

  2003cites this paper
• Functional Relationship and Gene Ontology Classification of Breast Cancer Biomarkers

  2003cites this paper
• Flow cytometry vs. Ki67 labelling index in breast cancer: a prospective evaluation of 181 cases.

  2002cites this paper
• Molecular prognostic indicators in breast cancer.

  2002cites this paper
• Prognostic comparative study of S-phase fraction and Ki-67 index in breast carcinoma

  2001cites this paper
• MIB‐1 Index, S‐Phase Fraction, Mitotic Figure Count, and SBR Histologic Grading in Invasive Breast Carcinoma: A Comparative Study

  2001cites this paper
• and Ki-67 index in breast carcinoma Prognostic comparative study of S-phase fraction

  2001cites this paper
• Isolation and Culture of Human Breast Cancer Cells from Primary Tumors and Metastases

  2000cites this paper
• p53 Protein expression and proliferative activity in ductal breast carcinomas

  2000cites this paper
• Comparison between different cell kinetic variables in human breast cancer.

  2000cites this paper
• Comparison between differentcell kinetic variables in human breast cancer

  2000cites this paper
• DNA ploidy and cell cycle distribution of breast cancer aspirate cells measured by image cytometry and analyzed by artificial neural networks for their prognostic significance

  1999cites this paper
• Histologic Grade and CD44 Are Independent Predictors of Axillary Lymph Node Invasion in Early (T1) Breast Cancer

  1999cites this paper
• Histamine, mast cells and tumour cell proliferation in breast cancer: does preoperative cimetidine administration have an effect?

  1999cites this paper
• Immunohistochemical Detection of Ki-67 and PCNA in Canine Mammary Tumors: Relationship to Clinical and Pathologic Variables

  1998cites this paper
• Fluorescence‐based analysis of DNA ploidy and cell proliferation within fine‐needle samplings of breast tumors

  1998cites this paper
• Fine Needle Aspiration Cytology of Glycogen-Rich Clear Cell Carcinoma of the Breast

  1998cites this paper
• Prognostic significance of proliferative activity, DNA‐ploidy, p53 and Ki‐ras point mutations in colorectal liver metastases

  1998cites this paper
• Neuroendocrine stains and proliferative indices of prostatic adenocarcinomas in transurethral resection samples.

  1997cites this paper
• Comparison between ki‐67 index and S‐phase fraction on fine‐needle aspiration samples from breast carcinoma

  1997cites this paper
• Prognostic significance of Ki-67 expression in transitional cell bladder carcinoma after radical cystectomy.

  1997cites this paper
• MIB-1 (Ki-67) immunostaining of breast cancer cells in cytologic smears.

  1997cites this paper
• Prognostic value of Ki-67 for recurrence and progression of superficial bladder cancer.

  1997cites this paper
• Prognostic impact of proliferation-associated factors MIB1 (Ki-67) and S-phase in node-negative breast cancer.

  1997cites this paper
• Morphometric determination of AgNORs in breast carcinoma. Correlation with flow cytometry and proliferating cell nuclear antigen.

  1997cites this paper
• Comparison of quantitative and semiquantitative methods of assessing MIB-1 with the S-phase fraction in breast carcinoma.

  1997cites this paper
• [Ki-67, marker of proliferation].

  1997cites this paper
• Cytological evaluation of biological prognostic markers from primary breast carcinomas

  1997cites this paper
• Intermediate filament expression of ductal carcinoma cells in fine needle aspirates of the breast.

  1997cites this paper
• Correlation Among MIB-1, Paraffin Section Proliferation Index, and Recurrence in Low-Stage Breast Carcinoma

  1997cites this paper
• Artificial neural networks in cancer research.

  1997cites this paper
• Prognostic value of Ki-67 compared to S-phase fraction in axillary node-negative breast cancer.

  1996cites this paper
• Methods to measure cell proliferation in haematology.

  1996cites this paper
• Comparison ofMIB-1proliferation indexwithS-phase fraction inhuman breast carcinomas

  1996cites this paper
• Quantitation of proliferation-associated markers Ag-NOR and Ki-67 does not contribute to the prediction of lymph node metastases in squamous cell carcinoma of the vulva.

  1996cites this paper
• Comparison of MIB-1 proliferation index with S-phase fraction in human breast carcinomas.

  1996cites this paper
• Multicentric breast carcinoma: Evaluation of clinicopathological and immunohistochemical characteristics

  1996cites this paper
• Prognostic significance of Ki-67 labeling index in urothelial tumors of the renal pelvis and ureter.

  1996cites this paper
• Flow Cytometric Proliferative Fraction Analysis in Solid Tumors

  1996cites this paper
• Correlations of morphology, proliferation indices, and oncogene activation in ductal breast carcinoma: nuclear grade, S-phase, proliferating cell nuclear antigen, p53, epidermal growth factor receptor, and c-erb-B-2.

  1995cites this paper
• [Prognostic significance of the S-phase and MIB1 (Ki-67) proliferation parameters in node-negative breast carcinoma].

  1995cites this paper
• Cellular proliferation in prostatic adenocarcinoma as assessed by bromodeoxyuridine uptake and Ki‐67 and PCNA expression

  1995cites this paper
• Proliferation markers in breast carcinoma. Mitotic figure count, S-phase fraction, proliferating cell nuclear antigen, Ki-67 and MIB-1.

  1995cites this paper
• S‐phase fraction and nuclear size in long term prognosis of patients with breast cancer

  1994cites this paper
• Relationship between Cytosol Tps, Tpa and Cell Proliferation

  1994cites this paper
• Overview of the biologic markers of breast cancer.

  1994cites this paper
• Proliferative activity and aneuploidy in pleomorphic adenomas of the salivary glands.

  1994cites this paper
• Can Ki67 immunostaining predict response to radiotherapy in oral squamous cell carcinoma?

  1994cites this paper
• Vimentin expression, proliferating cell nuclear antigen and flow cytometric factors. Prognostic role in breast cancer.

  1994cites this paper
• Modern Methods in Cytology

  1994cites this paper
• [Molecular markers to predict the prognosis of breast cancer].

  1993cites this paper
• Proliferating cell nuclear antigen (PCNA) immunolabeling as a prognostic factor in axillary lymph node negative breast cancer.

  1993cites this paper
• DNA ploidy, S-phase, and steroid receptors in more than 127,000 breast cancer patients

  1993influential citation
• Sequential identification of factors predicting distant relapse in breast cancer patients treated by conservative surgery

  1993cites this paper
• Prognostic value of cell proliferation in breast cancer as determined by proliferating cell nuclear antigen (PCNA) immunostaining.

  1992cites this paper
• Capability of various cytokines to induce quiescent myeloid leukemia cells to the proliferative stage.

  1992cites this paper
• p53 and c-erbB-2 protein expression in breast carcinomas. An immunohistochemical study including correlations with receptor status, proliferation markers, and clinical stage in human breast cancer.

  1992cites this paper
• DNA ploidy, proliferation, and neu-oncogene protein overexpression in breast carcinoma.

  1992cites this paper
• Nucleoside diphosphate kinase/NM23 expression in breast cancer: Lack of correlation with lymph‐node metastasis

  1992cites this paper
• Production of a monoclonal antibody (IND.64) identifying a cell cycle‐associated antigen using spleen cells from nude mice bearing ichikawa tumour

  1992cites this paper
• Growth fraction (Ki-67 antibody) determination in early-stage breast carcinoma: histologic, clinical and prognostic correlations

  1992cites this paper
• PCNA and Ki67 expression in breast carcinoma: correlations with clinical and biological variables.

  1992cites this paper
• [Should cell proliferation of breast cancer be quantified, and if so, which method should be used].

  1992cites this paper
• Grace Is Given by God, but Knowledge is Bought in the Market

  1992cites this paper
• [Ki-67 antigen, a cell cycle and tumor growth marker].

  1991cites this paper